Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-09-22
2000-04-04
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 72, 536 74, 536 185, A61K 3170, C07H 100, C07H 1708
Patent
active
060461713
ABSTRACT:
Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
REFERENCES:
patent: 4990602 (1991-02-01), Morimoto et al.
patent: 5403923 (1995-04-01), Kashimura et al.
patent: 5444051 (1995-08-01), Agouridas et al.
patent: 5527780 (1996-06-01), Agouridas et al.
Journal of Antibiotics, vol. 37. No. 2 (1984), pp. 187-189, Moritmoto, et al., "Chemical Modification of Erythromycins. I. Synthesis and Antibacterial Activity of 6-O-Methylerythromycins A".
Journal of Antibiotics, vol. 43, No. 3 (1990), pp. 286-292, Moritmoto, et al., "Chemical Modification of Erythromycins. II. Synthesis and Antibacterial Activity of O-Alkl Derivatives of Erythromycin A".
Chu Daniel T.
Griesgraber George
Li Leping
Or Yat Sun
Abbott Laboratories
Anand Mona
Peselev Elli
LandOfFree
6,11-bridged erythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6,11-bridged erythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,11-bridged erythromycin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365110